Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24 is a research paper published in Viruses (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AI109664
National Institutes of Health
Grant: P01AI120943
National Institutes of Health
Grant: R01AI143292
National Institutes of Health
Grant: R01AI123926
National Institutes of Health
Grant: R01AI161374
National Institutes of Health
Grant: R01AI148663
National Institutes of Health
Grant: AI07647
NIAID NIH HHS
Grant: T32 AI007647
NIAID NIH HHS
Grant: U19 AI109664
National Institutes of Health
Grant: 5R01AI148663-05
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
National Institutes of Health
Grant: 5P01AI120943-03
Structural and Functional Characterization of the Ebola Virus Replication Complex
National Institutes of Health
Grant: 5R01AI161374-02
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
National Institutes of Health
Grant: 3R01AI143292-05S1
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection
National Institutes of Health
Grant: 7U19AI109664-04
Therapeutics Targeting Filoviral interferon-antagonist and replication functions
National Institutes of Health
Grant: 5R01AI123926-02
Multi-platform High Throughput Screens for Filoviral Replication Inhibitors
FWCI
0.85
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals